Prediction of phenytoin dosage in epilepsy using multiple linear regression

Area of Science:

• Pharmacology
• Clinical Pharmacy
• Neurology

Background:

• Epilepsy management often involves phenytoin, an anticonvulsant medication.
• Maintaining therapeutic plasma phenytoin levels is crucial for effective seizure control.
• Suboptimal dosing can lead to treatment failure or adverse effects.

Purpose of the Study:

• To investigate the relationship between plasma phenytoin concentrations, patient body weight, and daily dosage.
• To develop an optimized dosing strategy for phenytoin based on these factors.
• To evaluate the impact of optimized dosing on achieving therapeutic plasma phenytoin levels.

Main Methods:

• Analysis of plasma phenytoin levels in epilepsy patients.
• Exploration of the correlation between plasma phenytoin, body weight, and daily dosage.
• Application of multiple regression analysis to derive a predictive equation.
• Implementation of the derived equation for optimizing drug dosage.

Main Results:

• Only 36% of patients initially had plasma phenytoin levels within the therapeutic range.
• A multiple regression equation was established to relate plasma phenytoin, body weight, and dosage.
• Optimized dosing based on body weight significantly increased the proportion of patients in the therapeutic range.
• The clinical significance of achieving therapeutic plasma phenytoin levels was demonstrated.

Conclusions:

• Patient body weight is a critical factor in optimizing phenytoin dosage.
• A weight-based dosing approach enhances the likelihood of achieving therapeutic plasma phenytoin concentrations.
• Optimized phenytoin therapy improves treatment efficacy and patient outcomes in epilepsy.